BIOSIMILARS Two biosimilars get US panel's nod

被引:0
|
作者
Mccoy, Michael
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:15 / 15
页数:1
相关论文
共 50 条
  • [41] A clinician's guide to biosimilars in oncology
    Rugo, Hope S.
    Linton, Kim M.
    Cervi, Paul
    Rosenberg, Julie A.
    Jacobs, Ira
    CANCER TREATMENT REVIEWS, 2016, 46 : 73 - 79
  • [42] Amgen's move into the biosimilars market
    不详
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2014, 3 (04): : 202 - 203
  • [43] Biosimilars: what's around the corner?
    Russell, Richard K.
    Irving, Peter
    Probert, Chris
    FRONTLINE GASTROENTEROLOGY, 2015, 6 (04) : 262 - 263
  • [44] Biologic product identification and US pharmacovigilance in the biosimilars era
    Thomas Felix
    Torbjörn T Johansson
    Jodi A Colliatie
    Michael R Goldberg
    Andrew R Fox
    Nature Biotechnology, 2014, 32 : 128 - 129
  • [45] Biosimilars: A cure to the US health care cost conundrum?
    Hirsch, Bradford R.
    Lyman, Gary H.
    BLOOD REVIEWS, 2014, 28 (06) : 263 - 268
  • [46] Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland
    Carl, David L.
    Laube, Yannic
    Serra-Burriel, Miquel
    Naci, Huseyin
    Ludwig, Wolf-Dieter
    Vokinger, Kerstin N.
    JAMA NETWORK OPEN, 2022, 5 (12) : E2244670
  • [47] Canada's approach to biosimilars questioned
    Webster, Paul Christopher
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (16) : 1199 - 1199
  • [48] Biosimilars in Italy: a gastroenterologist's view
    Annese, Vito
    Gabbani, Tommaso
    Annese, Antonio Luca
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2016, 5 (03): : 131 - 133
  • [49] Key factors for successful uptake of biosimilars: Europe and the US
    Reilly, Michael S.
    Schneider, Philip J.
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2022, 11 (03): : 112 - 124
  • [50] Biosimilars encircle Rituxan, US debates innovator exclusivity
    Carey, Karen
    NATURE BIOTECHNOLOGY, 2011, 29 (03) : 177 - 178